|
FY2025
12 months to Dec 31, 2025
|
FY2024
9 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares | ||
| Interest earned on investments held in Trust Account | ||
| Change in fair value of over-allotment option liability | ||
| Compensation expense | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Prepaid insurance | ||
| Deferred legal fees | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash into Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of private placement Units | ||
| Underwriters' reimbursement | ||
| Advance from related party | ||
| Proceeds from promissory note - related party | ||
| Repayment of promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash - Beginning of period | ||
| Cash - End of period | ||
| Supplemental disclosure of cash flow information: | ||
| Noncash investing and financing activities: | ||
| Offering costs included in accrued offering costs | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | ||
| Deferred underwriting fee payable | ||
| Deferred legal fee payable | ||
| Forfeiture of Founder Shares |
Loading...
